glp 1 osteoarthritis Glucagon-like peptide-1 receptor agonists in arthritis: current insights and future directions Do GLP1 Medications Regenerate Cartilage?

Function and therapeutic value of astrocytes in neurological diseases

doi: 10.3389/fphys.2018.01182 Received 28 April 2018 Accepted 06 August 2018 Published 23 August 2018 Volume 9 - 2018 Edited by Fan Wu, Fudan University, China Reviewed by Marcos Lopez, University of Chicago, United States

"GHK-Cu may be one of the most important molecules in human aging its decline correlates with the breakdown of virtually every tissue repair system

BODEN: Like, how is that happening

Pulmonary hypertension: 4.9% vs

The study "Liraglutide versus placebo as an adjunct to glucose-lowering therapy in patients with type 2 diabetes and moderate renal failure" (LIRA-RENAL) did not demonstrate a benefit of liraglutide in lowering eGFR, although the duration of the study (26 weeks) may have been insufficient to show an effect